Quality of Life in Cardiac Patient Research: A Meta-Analysis

Nursing Research

Volumn 45, Issue 3, 1996, Pages 173-180

  Kinney, Marguerite R ^a   Burfitt, Sandra N ^a   Stullenbarger, Elizabeth ^b   Rees, Barbara ^c   Debolt, Marie Read ^d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF CENTRAL FLORIDA   (United States)

^c Floyd College   (United States)

^d Baptist Health Care Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; EQUIPMENT; FEMALE; HEART DISEASE; HUMAN; MALE; MARRIAGE; META ANALYSIS; METHODOLOGY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SEX DIFFERENCE; TIME; TREATMENT OUTCOME;

AGED; CHI-SQUARE DISTRIBUTION; EFFECT MODIFIERS (EPIDEMIOLOGY); FEMALE; HEART DISEASES; HUMANS; MALE; MARITAL STATUS; MIDDLE AGED; QUALITY OF LIFE; RESEARCH DESIGN; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0030136804     PISSN: 00296562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006199-199605000-00009     Document Type: Article

References (117)

1. AARONSON, N. K. (1988). Quality of life: What is it? How should it be measured? Oncology, 2, 69-74.
2. AARONSON, N. K. (1990). Quality of life research in cancer clinical trials: A need for a common rules and language. Oncology, 4, 59-66.
3. AARONSON, N. K., BULLINGER, M., & AHMEDZAI, S. (1988). A modular approach to quality of life assessment. Recent Results in Cancer Research, 3, 231-249.
4. AARONSON, N. K., VAN DAM, F. S., POLAK, L. E., & ZITTOUN, R. (1986). Prospects and problems in European psychosocial oncology: A survey of the EORTC study group on quality of life. Journal of Psychosocial Oncology, 4, 43-53.
5. ABERG, H., & TIBBLIN, G. (1989). Addition of non-pharmacological methods of treatment in patients on antihypertensive drugs: Results of previous medication, laboratory tests and life quality. Journal of Internal Medicine, 226, 39-46.
6. AIVAZYAN, T. A., ZAITSEV, V. P., SALENKO, B. B., YURENEVE, A. P., & PATRUSHEVA, I. F. (1988). Efficacy of relaxation techniques in hypertensive patients. Health Psychology, 7(Suppl.), 193-200.
7. AMBROSIO, G. B., ZAMBONI, S., & BOTTA, G. (1988). Captopril in early hypertensive patients. American Journal of Medicine, 84, 152-154.
8. AMELING, E. H., DEKORTE, D. F., & MANINTVELD, A. J. (1991). Impact of diagnosis and treatment of hypertension on quality of life, a double-blind randomized placebo-controlled, cross-over study of betaxolol. Journal of Cardiovascular Pharmacology, 18, 752-760.
9. AMSTEIN, R., BUHLER, F. R., BERETTA-PICCOLI, C., BERTEL, O., BRUNNER, H. R., FOLLATH, F., HEER, K., REUTTER, F., & VALLOTTON, M. B. (1989). Antihypertensive efficacy and well-being during monotherapy and combination therapy with ketanserin. Journal of Hypertension, 7, 619-624.
10. APPLEGATE, W. B., PHILLIPS, H. L., SCHNAPER, H., SHEPHERD, A. M., SCHOCKEN, D., LUHR, J. C., KOCH, G. G., & PARK, G. D. (1991). A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women. Archives of Internal Medicine, 151, 1817-1823.
11. BALEADOO, S. J., SUBRATLY, H., MANROZ, M., FARRAL, A., MAITI, D., & MURDAY, M. (1990). Effects of enoximone on quality of life. International Journal of Cardiology, 28 (Suppl. 1), S29-S32.
12. BARABINO, A., GALBARIGGI, G., PIZZORNI, C., & LOTTI, G. (1991). Comparative effects of long-term therapy with captopril and ibopamine in chronic congestive heart failure in old patients. Cardiology, 78, 243-256.
13. BETO, J. A., & BANSAL, V. K. (1992). Quality of life in treatment of hypertension: A meta-analysis of clinical trials. American Journal of Hypertension, 5, 125-133.
14. BLACKWOOD, R., MAYOU, R. A., GARNHAM, J. C., ARMSTRONG, C., & BRYANT, B. (1990). Exercise capacity and quality of life in the treatment of heart failure. Clinical Pharmacology and Therapeutics, 48, 325-332.
15. BLAKE, P., BERRY, S. C., READMAN, A., RATCLIFFE, M., & GODLEY, M. (1991). A comparison of epanolol and nifidipine in stable angina patients: Results of a multicenter trial. Cardiology, 79, 249-255.
16. BLUMENATHAL, J. A., MADDEN, D. J., KRANTZ, D. S., LIGHT, K. C., MCKEE, D. C., EKELUND, L. G., & SIMON, J. (1988). Short-term behavioral effects of beta-adrenergic medications in men with mild hypertension. Clinical Pharmacology and Therapeutics, 43, 429-435.
17. BOON, N. A., FREW, A. J., JOHNSTON, J. A., & COBBS, S. M. (1987). A comparison of symptoms and intra-arterial ambulatory blood pressure during long term dual chamber atrioventricular sychronous (DDD and ventricular demand (VVI)) pacing. British Heart Journal, 58, 34-39.
18. BOOTH, D. C., DEUPREE, R. H., HULTGREN, H. N., DEMARIA, A. N., SCOTT, S. M., & LUCHI, R. J. (1991). Quality of life after bypass surgery for unstable angina. Five-year follow-up results of a Veterans' Affairs Cooperative Study. Circulation, 83, 87-95.
19. BRACCHETTI, D., GRADNIK, R., ALBERTI, A., BRUNELLI, A., ORSELLI, L., LEONARDI, G., PAVESI, P. C., & CANTELLI, I. (1990). A double-blind comparison of bisoprolol and catopril for treatment of essential hypertension in the elderly. Cardiovascular Drugs and Therapy, 4, 261-264.
20. THE CANADIAN ENALAPRIL STUDY GROUP. (1987). Comparison of monotherapy with enalapril and atenolol in mild to moderate hypertension. Canadian Medical Association Journal, 137, 803-808.
21. CAPONE, R. J., STABLEIN, D., VISCO, J., WAGNER, G., GORKIN, L., & FOLLICK, M. J. (1988). The effects of a transtelephonic surveillance and pre-hospital emergency intervention system on the 1-year course following acute myocardial infarction. American Heart Journal, 116, 1606-1615.
22. CELLA, D. F., & TULSKY, D. S. (1990). Measuring quality of life today: Methodological aspects. Oncology, 4, 29-38.
23. CHANG, S. W., FINE, R., SIEGEL, D., CHESNEY, M., BLACK, D., & HULLEY, S. B. (1991). The impact of diuretic therapy on reported sexual function. Archives of Internal Medicine, 151, 2,402-408.
24. CHATELLIER, G., SASSANO, P., AMIOT, A. M., CORVOL, P., & MENARD, J. (1987). Efficacy and influence on quality of life of enalapril as a first step treatment of hypertension. Clinical and Experimental Hypertension. Part A, Theory and Practice, 9, 513-519.
25. CLAMP, M., HOLMES, B., & WILCOX, R. (1990). Comparative trial of nifidipine retard and atenolol in the treatment of elderly patients with mild to moderate hypertension. Journal of Human Hypertension, 4, 557-563.
26. CLARK-TURNER, N. (1989). Comparative multicenter study of the tolerability and efficacy of epanolol versus metoprolol in patients with stable angina pectoris. Drugs. 38 (Suppl. 2), 55-60.
27. COHEN, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Erlbaum.
28. COOPER, H. M. (1989). Integrating research: A guide for literature reviews (2nd ed.). Newbury Park, CA: Sage.
29. CROOG, S. H., KONG, B. W., LEVINE, S., WEIR, M. R., BAUME, R. M., & SAUNDERS, E. (1990). Hypertensive black men and women: Quality of life and effects of antihypertensive medications. Archives of Internal Medicine, 150, 1733-1741.
30. CROOG, S. H., SUDILOVSKY, A., LEVINE, S., & TESTA, M. A. (1987). Work performance, absenteeism and antihypertensive medications. Journal of Hypertension, 5 (Suppl. 1), S47-S54.
31. DAHLOF, C., HEDNER, T., THULIN, T., GUSTAFSSON, S., & OLSSON, S. O. (1991). Effects of diltiazem and metoprolol on blood pressure, adverse symptoms and general well-being. The Swedish Diltiazem-Metoprolol Multi-Centre Study Group. European Journal of Clinical Pharmacology, 40, 453-460.
32. DEHAES, J. C., & VAN KNIPPENBERG, F. C. (1985). The quality of life of cancer patients: A review of the literature. Social Science and Medicine, 20, 809-817.
33. DIBIANCO, R. (1989). Clinical results with oral milrinone during heart failure. European Heart Journal, 10 (Suppl. C), 44-52.
34. DIMENAS, E., WALLENDAR, M. A., SVARDSUDD, K., & WIKLUND, I. (1991). Aspects of quality of life on treatment with felodipine. European Journal of Clinical Pharmacology, 40, 141-147.
35. DUBOURG, O., DELORME, G., HARDY, A., BEAUCHET, A., TARRAL, A., & BOURDARIAS, J. P. (1990). Placebo-controlled trial of oral enoximone in end-stage congestive heart failure refractor to optimal treatment. International Journal of Cardiology, 28 (Suppl. 1), S33-S42.
36. EDMONDS, D., GREMINGER, P., VETTER, W., BAUMGART, P., & VETTER, H. (1988, Feb. 29). The neglected time factor and antihypertensive therapy: A pitfall in evaluating side effects in a cross-over study. Postgraduate Medicine, 83, 40-45.
37. ERICKSON, H., & SWAIN, M. A. (1990). Mobilizing self-care resources: A nursing intervention for hypertension. Issues in Mental Health Nursing, 11, 217-235.
38. FAGHER, B., KATZMAN, P., HULTHEN, U. L., HENNINGSEN, N. C., & THULLIN, T. (1991). Antihypertensive efficacy and tolerability of enalpril and slow-release verpamil in essential hypertension: A double-blind, cross-over study. Journal of Internal Medicine, 230, 219-226.
39. FAYERS, P. M., & JONES, D. R. (1983). Measuring and analyzing quality of life in cancer clinical trials. Statistics in Medicine, 2, 429-446.
40. FELDMAN, A. M., BAUMAN, K. L., LEE, W. K., GOTTLIEB, S. H., WEISS, J. L., BECKER, L. C., & STROBECK, J. E. (1991). Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy. American Journal of Cardiology, 68, 1203-1210.
41. FLETCHER, A., HUNT, B., & BULPITT, C. (1987). Evaluation of quality of life in trials of cardiovascular disease. Journal of Chronic Disease, 40, 557-566.
42. FLETCHER, A., MCLOON, P., & BULPITT, C. (1988). Quality of life on angina therapy: A randomized controlled trial of transdermal glycerol trinitrate against placebo. Lancet, 2 (8601), 4-8.
43. FLETCHER, A. E., BEEVERS, D. G., DOLLERY, C. T., WILKINSON, R., & BLUPITT, C. J. (1991). The effects of two centrally-acting anti-hypertensive drugs on the quality of life. European Journal of Clinical Pharmacology, 41, 397-400.
44. FLETCHER, A. E., BULPITT, C. J., HAWKINS, C. M., HAVINGA, T. K., TENBERGE, B. S., MAY, J. F., SCHUURMAN, F. H., VAN-DER-VEUR, E., & WESSELING, H. (1990). Quality of life on antihypertensive therapy: A randomized double-blind controlled trial of captopril and atenolol. Journal of Hypertension, 8, 463-466.
45. FLETCHER, A. E., CHESTER, P. C., HAWKINS, C. M., LATHAM, A. N., PIKE, L. A., & BULPITT, C. J. (1989). The effects of verapamil and propranolol on quality of life in hypertension. Journal of Human Hypertension, 3, 125-130.
46. FODOR, J. G., & CHOCKALINGAM, A. (1991). Treatment of mild hypertension. Journal of Cardiovascular Pharmacology, 18 (Suppl. 1), S25-S28.
47. FRIDLUND, B., HOGSTEDT, B., LINDELL, E., & LARSSON, P. A. (1991). Recovery after myocardial infarction: Effects of a caring rehabilitation programme. Scandinavian Journal of Caring Sciences, 5 (1), 23-32.
48. FRIMODT-MOELLER, J., POULSEN, D. L., KORNERUP, H. J., & BECH, P. (1991). Quality of life, efficacy and side effects of lisinopril compared with metoprolol in patients with mild to moderate essential hypertension. Journal of Human Hypertension, 5, 215-221.
49. GILES, T. D., KATZ, R., SULLIVAN, J. M., WOLFSON, P., HAUGLAND, M., KIRLIN, P., POWERS, E., RICH, S., HACKSHAW, B., CHIARAMIDA, A., ROULEAU, J. L., FISHER, M. B., PIGEON, P., RUSH, J. E. FOR THE MULTICENTER LISINOPRIL-CAPTOPRIL CONGESTIVE HEART FAILURE STUDY GROUP (1989). Short and long acting angiotensin converting enzyme inhibitors: A randomized trial of lisinoporil versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group. Journal of the American College of Cardiology, 13, 1240-1247.
50. GILL, T. M. & FEINSTEIN, A. R. (1994). A critical appraisal of the quality of quality-of-life measurements. Journal of the American Medical Association, 272, 619-626.
51. GRAN, B. (1991). Non-pharmacological methods reduce drug use in the treatment of hypertension: A two-year trial in general practice. Scandinavian Journal of Primary Health Care, 9, 121-128.
52. GUYATT, G. H., SULLIVAN, M. J., FALLEN, E. L., TIHAL, H., RIDEOUT, E., HALCROW, S., NOGRADI, S., TOWNSEND, M., & TAYLOS, D. W. (1988). A controlled trial of digoxin in congestive heart failure. American Journal of Cardiology, 61, 371-375.
53. HEDGES, L. V., & OLKIN, I. (1985). Statistical methods for meta-analysis. Orlando, FL: Academic Press.
54. HEDMAN, A., & NORDLANDER, R. (1989). QT sensitive rate responsive pacing compared to fixed rate ventricular inhibited pacing: A controlled clinical study. PACE. Pacing and Clinical Electrophysiology, 12, 374-385.
55. HERLITZ, J., BENGTSON, A., WIKLUND, I., & HJALMARSON, A. (1988). Morbidity and quality of life 5 years after early intervention with metoprolol in suspected acute myocardial infarction. Cardiology, 75, 357-364.
56. HERRICK, A. L., WALLER, P. C., BERKIN, K. E., PRINGLE, S. D., CALLENDAR, J. S., ROBERTSON, M. P., FINDLAY, J. G., MURRAY, G. D., REID, J. L., LORIMER, A. R., WEIR, R. I., CARMICHAEL, H. A., ROBERTSON, J. T., BLL, S. G., & MCINNES, G. T. (1989). Comparison of enalapril to atenolol in mild to moderate hypertension. American Journal of Medicine, 86, 421-426.
57. HOLLANDSWORTH, J. G. (1988). Evaluating the impact of medical treatment on the quality of life: A 5-year update. Social Science and Medicine, 26, 425-434.
58. HUNTER HYPERTENSION RESEARCH GROUP. (1991). Well-being and its measurement in hypertension: A randomized double-blind cross-over comparison of 5 mg clopamide with 225 mg hydrochlorothiazide. Clinical and Experimental Hypertension. Theory and Practice A, 13 (2), 189-195.
59. THE ITALIAN XAMOTEROL MULTICENTER RESEARCH GROUP. (1990). Comparative effects of xamoterol and digoxin in patients with mild to moderate heart failure. European Heart Journal, 11 (Suppl. A), 50-51.
60. JERN, S. (1989). The effects of epanolol on quality of life. Drugs, 38 (Suppl. 2), 71-74.
61. JERN, S., HANSSON, L., SCHERSTEN, B., KULLMAN, S., SORENSEN, S., DAHLOF, B., EGGERTSEN, R., & SIVERTSSON, R. (1991). Swedish Isradipine Study in Hypertension: Evaluation of quality of life, safety and efficacy. SWISH group. Journal of Cardiovascular Pharmacology, 18 (Suppl. 3), S7-S8.
62. JOBE, J. B., & MINGAY, D. J. (1990). Cognitive laboratory approach to designing questionnaires for surveys of the elderly. Public Health Reports, 105, 518-524.
63. KAY, G. N., BUBIEN, R. S., EPSTEIN, A. E., & PLUMB, V. J. (1988). Effect of catheter ablation of the atrioventricular junction on quality of life and exercise tolerance in paroxysmal atrial fibrillation. American Journal of Cardiology, 62, 741-744.
64. KENDALL, M. G. (1948). Rank correlation methods (4th ed.). New York, NY: Hatter.
65. KIOWSKI, W., DREXLER, H., MEINERTZ, T., ZUBER, M., RITZ, R., BURKART, F., & JUST, H. (1991). Cilazapril in congestive heart failure: A pilot study. Drugs, 41(Suppl. 1), 54-61.
66. KUTNER, N. G., ORY, M. G., BAKER, D. I., SCHECTMAN, K. B., HORNBROOK, M. C., & MULROW, C. D. (1992). Measuring the quality of life of the elderly in health promotion intervention clinical trials. Public Health Reports, 107, 530-539.
67. LACOURCIERE, Y. (1988). Analysis of well-being and 24-hour blood pressure recording in a comparative study between indapamide and captopril. American Journal of Medicine, 84, 47-52.
68. LEIER, C. V., BINKLEY, P. F., STARLING, R. C., & HUSS-RANDOLPH, P. (1989). Disparity between improvement in left ventricular function and changes in clinical status and exercise capacity during chronic enoximone therapy. American Heart Journal, 117, 1092-1098.
69. LINDVALL, K., ERIKSSON, S. V., LAGERSTRAND, L., & SJOGREN, A. (1988). Efficacy and tolerability of transdermal nitroglycerine in heart failure. A noninvasive placebo controlled double-blind cross-over study. European Heart Journal, 9, 373-379.
70. MCCARTHY, S. T., MCCARTHY, G. L., JOHN, S. M., & GOULD, S. E. (1990). A placebo-controlled crossover study of ketanserin in elderly hypertensive patients. Cardiovascular Drugs and Therapy, 4 (Suppl. 1), 115-117.
71. MCMAHON, F. G., JAIN, A. K., VARGAS, R., & FILLINGIM, J. (1990). A double-blind comparison of transdermal clonidine and oral captopril in essential hypertension. Clinical Therapeutics, 12, 88-100.
72. MENDES DE LEON, C. F., POWELL, L. H., & KAPLAN, B. H. (1991). Change in coronary-prone behaviors in the recurrent coronary prevention project. Psychosomatic Medicine, 53 407-409.
73. MENOZZI, C., BRIGNOLE, M., MORACCHINI, P. V., LOLLI, G., BACCHI, M., TESORIERI, M. C., TOSONI, G. D., & BOLLONI, R. (1990). Intrapatient comparison between chronic VVIR and DDD pacing in patients affected by high degree AV block without heart failure. PACE. Pacing and Clinical Electrophysiology, 12, 401-405.
74. MOINPOUR, C. M., FEIGL, P., METCH, B., HAYDEN, K. A., MEYSKENS, F. L., & CROWLEY, J. (1989). Quality of life end points in cancer clinical trials: Review and recommendations. Journal of the National Cancer Institute, 81, 485-495.
75. MULTICENTER RESEARCH GROUP. (1990). A placebo-controlled, randomized, double-blind study of OPC 8212. Cardiovascular Drugs and Therapy, 4, 419-425.
76. NISSINEN, A., WIKLUND, I., LAHTI, T., AKKILA, J., WILSON, A., WAHL, M., & PUSKA, P. (1991). Anti-anginal therapy and quality of life: A comparison of the effects of transdermal nitroglycerine and long-acting oral nitrates. Journal of Clinical Epidemiology, 44, 989-997.
77. OLDRIDGE, N., GUYATT, G., JONES, N., CROWE, J., SINGER, J., FEENY, D., MCKELVIE, R., RUNIONS, J., STREINER, D., & TORRENCE, G. (1991). Effects on quality of life on comprehensive rehabilitation after acute myocardial infarction. American Journal of Cardiology, 67, 1084-1089.
78. ORY, M. G. (1988). Considerations in die development of age-sensitive indicators for assessing health promotion. Health Promotion, 3, 139-150.
79. Os, I., BRATLAND, B., DAHLOF, B., GISHOLT, K., SYVERTSON, J. O., & TRETLI, S. (1991). Lisinopril or nifidipine in essential hypertension?: A Norwegian multicenter study on efficacy, tolerability and quality of life in 828 patients. Journal of Hypertension, 9, 1097-1104.
80. OTO, M. A., MUDDERISOGLU, H., OZIN, M. B., KORKMAZ, M. E., KARAMEHMETOGLU, A., ORAM, M., ORAM, E., & UGURLU, S. (1991). Quality of life in patients with rate responsive pacemakers: A randomized cross-over study. PACE. Pacing and Clinical Electrophysiology, 14, 800-806.
81. OTTEN, H., SCHMEIDER, R., & RUDDELL, H. (1987). Disparate effects of initial antihypertensive therapy on well-being. Journal of Hypertension, 5 (Suppl. 1), S37-S40.
82. O'YOUNG, J., & MCPEEK, B. C. (1987). Quality of life variables in surgical trials. Journal of Chronic Disease, 40, 513-522.
83. PALMER, A., FLETCHER, A., HAMILTON, G., MURISS, S., & BULPITT, C. (1990). A comparison of verapamil and nifidipine on quality of life. British Journal of Clinical Pharmacology, 30, 365-370.
84. PATRICK, D. L. (1992). Health-related quality of life in pharmaceutical evaluation: Forging progress and avoiding pitfalls. PharmacoEconomics, 1, 76-78.
85. PEDUZZI, P., HULTGREN, H., THOMSEN, J., & DETRE, K. (1987). Ten-year effect of medical and surgical therapy on quality of life: Veteran administration cooperative study of coronary artery surgery. The American Journal of Cardiology, 59, 1017-1023.
86. REDIKAR, D. E., EAGLE, K. A., HOMMA, S., GILLAM, L. D., & HARTHORNE, J. W. (1988). Clinical and hemodynamic comparison of VVI versus DDD pacing in patients with DDD pacemakers. American Journal of Cardiology, 161, 323-329.
87. RICHTER, A., HERLITZ, J., & HJALMARSON, A. (1991). Effect of acupuncture in patients with angina pectoris. European Heart Journal, 12, 175-178.
88. ROSENTHAL R. (1978). Combining results of independent studies. Psychological Bulletin, 85, 185-193.
89. ROSENTHAL R. (1979). The "file drawer problem" and tolerance for null results. Psychological Bulletin, 86, 638-041.
90. ROSENTHAL, R., & RUBIN, D. (1982). Comparing the effect sizes of independent studies. Psychological Bulletin, 92, 500-504.
91. SCHUMACHER, M., OLSCHEWSKI, M., & SCHULGEN, G. (1991). Assessment of quality of life in clinical trials. Statistics in Medicine, 10, 1915-1930.
92. SMITH, M. C. (1988). Meta-analysis of nursing intervention research. Birmingham, AL: Birmingham Printing and Publishing.
93. SMITH, M. C., & STULLENBARGER, E. (1991). A prototype for integrative review and meta-analysis of nursing research. Journal of Advanced Nursing, 16, 1271-1283.
94. SMITH, M. L., GLASS, G. V., & MILLER, T. I. (1980). Benefits of psychotherapy. Baltimore, MD: Johns Hopkins University Press.
95. SPITZER, W. O. (1987). State of science 1986: Quality of life and functional status as target variables for research. Journal of Chronic Disease, 40, 465-471.
96. STEINER, S. S., FRIEDHOFF, A. J., WILSON, B. L., WECKER, J. R., & SANTO, J. P. (1990). Antihypertensive therapy and quality of life: A comparison of atenolol, captopril, enalapril and propanolol. Journal of Human Hypertension, 4, 217-225.
97. SULKE, N., CHAMBERS, J., DRITSAS, A., & SOWTON, E. (1991). A randomized double-blind crossover comparison of four rate-responsive pacing modes. Journal of the American College of Cardiology, 17, 696-706.
98. SULKE, N., DRITSAS, A., CHAMBERS, J., & SOWTON, E. (1990). Is accurate rate response programming necessary? PACE. Pacing and Clinical Electrophysicology, 13, 1031-1044.
99. SUNDAR, S., RAJAN, A. G., SOMANI, P. N., & KUMAR, K. (1991). The effects of antihypertensive agents on the quality of life in Indian hypertensives. Acta Cardiologica, 46, 227-235.
100. TANDON, P. K., STANDER, H., & SCHWARZ, JR., R. P. (1989). Analysis of quality of life data from a randomized, placebo-controlled heart-failure trial. Journal of Clinical Epidemiology, 42, 955-962.
101. TCHEKMEDYIAN, N. S., & CELLA, D. F. (1990). Response to Dr. Aaronson's article. Oncology, 4, 70.
102. TESTA, M. A., HOLLENBERG, N. K., ANDERSON, R. B., & WILLIAMS, G. H. (1991). Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifidipine gastrointestinal therapeutic system. American Journal of Hypertension, 4, 363-373.
103. TIMEWELL, R. M., STARK, R. D., & MARLOW, H. F. (1990). Xamoterol monotherapy in heart failure. The European 'Corwin' Group. European Heart Journal. 11(Suppl. A), 62-64.
104. THE TREATMENT OF MILD HYPERTENSION RESEARCH GROUP. (1991). The treatment of mild hypertension study: A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. Archives of Internal Medicine, 151, 1413-1423.
105. TURNER, J. F., GOULD, S. E., WELBURN, P. J., & WHITEHEAD, P. A. (1987). The effect of antihypertensive treatment on the assessment of well-being in a general practice population. Journal of Hypertension, 5 (Suppl. 5), S529-S531.
106. VAN DIXHOORN, J., DUIVENVOORDEN, H. J., POOL, J., & VERHAGE, F. (1990). Psychic effects of physical training and relaxation therapy after myocardial infarction. Journal of Psychosomatic Research, 34, 327-337.
107. VAN ZANTEN, S. J. O. V. (1991). Quality of life as outcome measures in randomized clinical trials. Controlled Clinical Trials, 12 (Suppl.), 234S-242S.
108. VERMEER, F., SIMOONS, M. L., DE ZWAAN, C., VAN ES, G. A., VERHEUGT, F. W., VAN DER LAARSE, A., VAN HOOGENHUYZE, D. C. A., AZAR, A. J., VAN DALEN, F. J., LUBSEN, J., & HUGENHOLTZ, P. G. (1988). Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase: Twelve month follow up report of the randomized multicenter trial conducted by the Interuniversity Cardiology Institute of the Netherlands. British Heart Journal, 59, 527-534.
109. WALLER, D. G., WEBSTER, J., SYKES, C. A., BHALLA, K. K., & WRAY, R. (1989). Clinical efficacy of xamoterol, a beta 1-adrenoceptor partial agonist, in mild to moderate heart failure. U.K. Xamoterol Study Group. European Heart Journal, 10, 1003-1010.
110. WASSERTHEIL-SMOLLER, S., BLAUFOX, M. D., OBERMAN, A., DAVIS, B. R., SWENCIONIS, C., KNERR, M. O., HAWKINS, C. M., & LANGFORD, H. G. (1991). Effect of antihypertensives on sexual function and quality of life: The TIAM study. The Annals of Internal Medicine, 114, 613-620.
111. WEIR, M. R., JOSSELSON, J., EKELUND, L. G., KORC, M., POOL, J. L., STEIN, G. H., WOLBACH, R. A., & CHAMPION, D. (1991). Nicardipine as antihypertensive monotherapy: Positive effects on quality of life. Journal of Human Hypertension, 5, 205-213.
112. WELZEL, D., BURGER, K. J., & WEINDINGER, G. (1990). Calcium antagonists as first-line antihypertensive agents: A placebo-controlled, comparative trial of isradipine and nifedipine. Journal of Cardiovascular Pharmacology, 15 (Suppl. 1), S70-S74.
113. WENGER, N. K. (1990). Quality of life in chronic cardiovascular illness. Journal of Cardiopulmonary Rehabilitation, 10, 88-91.
114. WERNING, C., WEITZ, T., & LUDWIG, B. (1988). Assessment of indapamide in early hypertensive patients with special emphasis on well-being. American Journal of Medicine, 84, 104-108.
115. WILLIAMS, G. H., CROOG, S. H., LEVINE, S., TESTA, M. A., & SUDILOVSKY, A. (1987). Impact of antihypertensive therapy on quality of life: Effect of hydrochlorothiazide. Journal of Hypertension, 5 (Suppl. 1), S29-S35.
116. WORTMAN, P., & YEATON, W. A. (1985). Cumulating quality of life results in controlled trials of coronary artery bypass surgery. Controlled Clinical Trials, 6, 289-305.
117. ZACHARIAH, P. K., BROBYN, R., KANN, J., LEVY, B., MARGOLIS, R., MCMAHON, F. G., REEVES, R., SPERLING, D. C., SWEET, D., ZAGER, P., ET AL. (1988). Comparison of quality of life on nitendipine and propanolol. Journal of Cardiovascular Pharmacology, 12 (Suppl. 4), S29-S35.